Feasibility of Adjuvant Chemotherapy With S-1 Consisting of a 4-Week Administration and a Two-Week Rest Period in Patients With Completely Resected Non-Small Cell Lung Cancer

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2012.6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program

Clinical Cancer Research
Cancer ResearchOncology
2007English

Feasibility and Efficacy of Adjuvant Chemotherapy With a Split-Dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients With Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer -A Retrospective Analysis-

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2013English

Adherence and Feasibility of 2 Treatment Schedules of S-1 as Adjuvant Chemotherapy for Patients With Completely Resected Advanced Lung Cancer: A Multicenter Randomized Controlled Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Comparison of Concurrent Chemoradiotherapy Versus Sequential Radiochemotherapy in Patients With Completely Resected Non-Small Cell Lung Cancer

Radiation Oncology Journal
OncologyRadiologyNuclear MedicineImaging
2016English

Adjuvant Therapy for Resected Non–Small-Cell Lung Cancer With Lymphovascular Invasion

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2013English

P2.16-45 Should Patients With Stage IB Non-Small Cell Lung Cancer Receive Adjuvant Chemotherapy?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Neutrophil-Lymphocyte Ratio Predicts Recurrence in Patients With Resected Stage 1 Non-Small Cell Lung Cancer

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy